{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:04:37Z","timestamp":1783134277430,"version":"3.54.6"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s10787-022-00932-0","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T15:02:31Z","timestamp":1646233351000},"page":"385-396","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Osteopontin in autoimmune disorders: current knowledge and future perspective"],"prefix":"10.1007","volume":"30","author":[{"given":"Canhua","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaohong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9311-9366","authenticated-orcid":false,"given":"Ning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,2]]},"reference":[{"key":"932_CR1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1876894600901010059","volume":"1","author":"MF Afify","year":"2009","unstructured":"Afify MF, Mohamed GB, El-Maboud MMA, Abdel-Latif EA (2009) Plasma concentration of osteopontin (OPN) in children with systemic lupus erythematosus: relationship with disease activity. Open Autoimmun J 1:59\u201363","journal-title":"Open Autoimmun J"},{"issue":"1","key":"932_CR2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190252","volume":"13","author":"E Agah","year":"2018","unstructured":"Agah E, Zardoui A, Saghazadeh A, Ahmadi M, Tafakhori A, Rezaei N (2018) Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: a systematic review and meta-analysis. PLoS ONE 13(1):e0190252","journal-title":"PLoS ONE"},{"key":"932_CR3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.imlet.2021.01.007","volume":"232","author":"G Asadi","year":"2021","unstructured":"Asadi G, Varmaziar FR, Karimi M, Rajabinejad M, Ranjbar S, Karaji AG et al (2021) Determination of the transcriptional level of long non-coding RNA NEAT-1, downstream target microRNAs, and genes targeted by microRNAs in diabetic neuropathy patients. Immunol Lett 232:20\u201326","journal-title":"Immunol Lett"},{"issue":"5454","key":"932_CR4","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1126\/science.287.5454.860","volume":"287","author":"S Ashkar","year":"2000","unstructured":"Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S et al (2000) Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287(5454):860\u2013864","journal-title":"Science"},{"issue":"2","key":"932_CR5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1530\/EJE-15-0791","volume":"174","author":"I Barchetta","year":"2015","unstructured":"Barchetta I, Alessandri C, Bertoccini L, Cimini F, Taverniti L, Di Franco M et al (2015) Increased circulating osteopontin levels in adult patients with type 1 diabetes mellitus and association with dysmetabolic profile. Eur J Endocrinol 174(2):187\u2013192","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"932_CR6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nrc2345","volume":"8","author":"A Bellahc\u00e8ne","year":"2008","unstructured":"Bellahc\u00e8ne A, Castronovo V, Ogbureke KU, Fisher LW, Fedarko NS (2008) Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer. Nat Rev Cancer 8(3):212\u2013226","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"932_CR7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.coi.2009.09.011","volume":"21","author":"M Bettini","year":"2009","unstructured":"Bettini M, Vignali DA (2009) Regulatory T cells and inhibitory cytokines in autoimmunity. Curr Opin Immunol 21(6):612\u2013618","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"932_CR8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/annrheumdis-2011-200298","volume":"71","author":"M Boumans","year":"2012","unstructured":"Boumans M, Houbiers J, Verschueren P, Ishikura H, Westhovens R, Brouwer E et al (2012) Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept study. Ann Rheum Dis 71(2):180\u2013185","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"932_CR9","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archneur.65.5.633","volume":"65","author":"M Braitch","year":"2008","unstructured":"Braitch M, Nunan R, Niepel G, Edwards LJ, Constantinescu CS (2008) Increased osteopontin levels in the cerebrospinal fluid of patients with multiple sclerosis. Arch Neurol 65(5):633\u2013635","journal-title":"Arch Neurol"},{"issue":"5547","key":"932_CR10","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1126\/science.1062960","volume":"294","author":"D Chabas","year":"2001","unstructured":"Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT et al (2001) The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294(5547):1731\u20131735","journal-title":"Science"},{"issue":"4","key":"932_CR11","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1182\/blood-2003-05-1748","volume":"103","author":"A Chiocchetti","year":"2004","unstructured":"Chiocchetti A, Indelicato M, Bensi T, Mesturini R, Giordano M, Sametti S et al (2004) High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity\/lymphoproliferation. Blood 103(4):1376\u20131382","journal-title":"Blood"},{"issue":"1","key":"932_CR12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1042\/BJ20050341","volume":"390","author":"B Christensen","year":"2005","unstructured":"Christensen B, Nielsen MS, Haselmann KF, Petersen TE, S\u00f8rensen ES (2005) Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications. Biochem J 390(1):285\u2013292","journal-title":"Biochem J"},{"issue":"27","key":"932_CR13","doi-asserted-by":"crossref","first-page":"19463","DOI":"10.1074\/jbc.M703055200","volume":"282","author":"B Christensen","year":"2007","unstructured":"Christensen B, Kazanecki CC, Petersen TE, Rittling SR, Denhardt DT, S\u00f8rensen ES (2007) Cell type-specific post-translational modifications of mouse osteopontin are associated with different adhesive properties. J Biol Chem 282(27):19463\u201319472","journal-title":"J Biol Chem"},{"issue":"6","key":"932_CR14","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1074\/jbc.M111.277996","volume":"287","author":"B Christensen","year":"2012","unstructured":"Christensen B, Kl\u00e4ning E, Nielsen MS, Andersen MH, S\u00f8rensen ES (2012) C-terminal modification of osteopontin inhibits interaction with the \u03b1V\u03b23-integrin. J Biol Chem 287(6):3788\u20133797","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"932_CR15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jneuroim.2004.09.004","volume":"158","author":"M Comabella","year":"2005","unstructured":"Comabella M, Pericot I, Goertsches R, Nos C, Castillo M, Navarro JB et al (2005) Plasma osteopontin levels in multiple sclerosis. J Neuroimmunol 158(1\u20132):231\u2013239","journal-title":"J Neuroimmunol"},{"key":"932_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/212893","author":"C Comi","year":"2012","unstructured":"Comi C, Cappellano G, Chiocchetti A, Orilieri E, Buttini S, Ghezzi L et al (2012) The impact of osteopontin gene variations on multiple sclerosis development and progression. Clin Dev Immunol. https:\/\/doi.org\/10.1155\/2012\/212893","journal-title":"Clin Dev Immunol"},{"issue":"3","key":"932_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/jcp.20701","volume":"208","author":"AP Da Silva","year":"2006","unstructured":"Da Silva AP, Pollett A, Rittling SR, Denhardt DT, Sodek J, Zohar R (2006) Exacerbated tissue destruction in DSS-induced acute colitis of OPN-null mice is associated with downregulation of TNF-alpha expression and non-programmed cell death. J Cell Physiol 208(3):629\u2013639. https:\/\/doi.org\/10.1002\/jcp.20701","journal-title":"J Cell Physiol"},{"issue":"10","key":"932_CR18","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/labinvest.2009.80","volume":"89","author":"APB da Silva","year":"2009","unstructured":"da Silva APB, Ellen RP, S\u00f8rensen ES, Goldberg HA, Zohar R, Sodek J (2009) Osteopontin attenuation of dextran sulfate sodium-induced colitis in mice. Lab Invest 89(10):1169\u20131181. https:\/\/doi.org\/10.1038\/labinvest.2009.80","journal-title":"Lab Invest"},{"issue":"9","key":"932_CR19","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1172\/JCI12980","volume":"107","author":"DT Denhardt","year":"2001","unstructured":"Denhardt DT, Noda M, O\u2019Regan AW, Pavlin D, Berman JS (2001) Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Investig 107(9):1055\u20131061","journal-title":"J Clin Investig"},{"issue":"3","key":"932_CR20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(08)70042-5","volume":"7","author":"GC Ebers","year":"2008","unstructured":"Ebers GC (2008) Environmental factors and multiple sclerosis. Lancet Neurol 7(3):268\u2013277","journal-title":"Lancet Neurol"},{"issue":"3","key":"932_CR21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.yexcr.2009.10.019","volume":"316","author":"B Ek-Rylander","year":"2010","unstructured":"Ek-Rylander B, Andersson G (2010) Osteoclast migration on phosphorylated osteopontin is regulated by endogenous tartrate-resistant acid phosphatase. Exp Cell Res 316(3):443\u2013451","journal-title":"Exp Cell Res"},{"issue":"3","key":"932_CR22","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1097-2765(01)00320-3","volume":"8","author":"H-YC Emily","year":"2001","unstructured":"Emily H-YC, Wei MC, Weiler S, Flavell RA, Mak TW, Lindsten T, Korsmeyer SJ (2001) BCL-2, BCL-XL sequester BH3 domain-only molecules preventing BAX-and BAK-mediated mitochondrial apoptosis. Mol Cell 8(3):705\u2013711","journal-title":"Mol Cell"},{"issue":"14","key":"932_CR23","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1038\/sj.onc.1208421","volume":"24","author":"A Essafi","year":"2005","unstructured":"Essafi A, de Mattos SF, Hassen YA, Soeiro I, Mufti GJ, Thomas NSB et al (2005) Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells. Oncogene 24(14):2317\u20132329","journal-title":"Oncogene"},{"issue":"7","key":"932_CR24","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1002\/art.23490","volume":"58","author":"K Fan","year":"2008","unstructured":"Fan K, Dai J, Wang H, Wei H, Cao Z, Hou S et al (2008) Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells. Arthritis Rheumatism 58(7):2041\u20132052","journal-title":"Arthritis Rheumatism"},{"issue":"3","key":"932_CR25","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/ana.25808","volume":"88","author":"M Filippi","year":"2020","unstructured":"Filippi M, Preziosa P, Langdon D, Lassmann H, Paul F, Rovira \u00c0 et al (2020) Identifying progression in multiple sclerosis: new perspectives. Ann Neurol 88(3):438\u2013452","journal-title":"Ann Neurol"},{"issue":"2","key":"932_CR26","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1006\/bbrc.2000.4146","volume":"280","author":"L Fisher","year":"2001","unstructured":"Fisher L, Torchia D, Fohr B, Young M, Fedarko N (2001) Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin. Biochem Biophys Res Commun 280(2):460\u2013465","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"932_CR27","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1042\/bj2320715","volume":"232","author":"A Franzen","year":"1985","unstructured":"Franzen A, Heineg\u00e5rd D (1985) Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochem J 232(3):715\u2013724","journal-title":"Biochem J"},{"issue":"4","key":"932_CR28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/exd.12649","volume":"24","author":"DF Frenzel","year":"2015","unstructured":"Frenzel DF, Borkner L, Scheurmann J, Singh K, Scharffetter-Kochanek K, Weiss JM (2015) Osteopontin deficiency affects imiquimod-induced psoriasis-like murine skin inflammation and lymphocyte distribution in skin, draining lymph nodes and spleen. Exp Dermatol 24(4):305\u2013307. https:\/\/doi.org\/10.1111\/exd.12649","journal-title":"Exp Dermatol"},{"issue":"3","key":"932_CR29","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1136\/annrheumdis-2013-204581","volume":"74","author":"S Gazal","year":"2015","unstructured":"Gazal S, Sacre K, Allanore Y, Teruel M, Goodall AH, Tohma S et al (2015) Identification of secreted phosphoprotein 1 gene as a new rheumatoid arthritis susceptibility gene. Ann Rheum Dis 74(3):e19\u2013e19","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"932_CR30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2012.12.003","volume":"331","author":"E Gimba","year":"2013","unstructured":"Gimba E, Tilli T (2013) Human osteopontin splicing isoforms: known roles, potential clinical applications and activated signaling pathways. Cancer Lett 331(1):11\u201317","journal-title":"Cancer Lett"},{"issue":"9","key":"932_CR31","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.2337\/dc14-0065","volume":"37","author":"D Gordin","year":"2014","unstructured":"Gordin D, Forsblom C, Panduru NM, Thomas MC, Bjerre M, Soro-Paavonen A et al (2014) Osteopontin is a strong predictor of incipient diabetic nephropathy, cardiovascular disease, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 37(9):2593\u20132600. https:\/\/doi.org\/10.2337\/dc14-0065","journal-title":"Diabetes Care"},{"issue":"1","key":"932_CR32","first-page":"49","volume":"114","author":"J Grassinger","year":"2009","unstructured":"Grassinger J, Haylock DN, Storan MJ, Haines GO, Williams B, Whitty GA et al (2009) Thrombin-cleaved osteopontin regulates hemopoietic stem and progenitor cell functions through interactions with \u03b19\u03b21 and \u03b14\u03b21 integrins. Blood, J Am Soc Hematol 114(1):49\u201359","journal-title":"Blood, J Am Soc Hematol"},{"issue":"6","key":"932_CR33","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s40291-014-0117-0","volume":"18","author":"VK Harris","year":"2014","unstructured":"Harris VK, Sadiq SA (2014) Biomarkers of therapeutic response in multiple sclerosis: current status. Mol Diagn Ther 18(6):605\u2013617","journal-title":"Mol Diagn Ther"},{"issue":"2","key":"932_CR34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/1756-185X.14021","volume":"24","author":"A Hejrati","year":"2021","unstructured":"Hejrati A, Hasani B, Esmaili M, Bashash D, Tavakolinia N, Zafari P (2021) Role of exosome in autoimmunity, with a particular emphasis on rheumatoid arthritis. Int J Rheum Dis 24(2):159\u2013169","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"932_CR35","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/cells9010072","volume":"9","author":"HS Howe","year":"2020","unstructured":"Howe HS, Leung BPL (2020) Anti-cytokine autoantibodies in systemic lupus erythematosus. Cells 9(1):72","journal-title":"Cells"},{"issue":"1","key":"932_CR36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ni1415","volume":"8","author":"EM Hur","year":"2007","unstructured":"Hur EM, Youssef S, Haws ME, Zhang SY, Sobel RA, Steinman L (2007) Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat Immunol 8(1):74\u201383","journal-title":"Nat Immunol"},{"issue":"1","key":"932_CR37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.clim.2014.12.010","volume":"157","author":"S Husain-Krautter","year":"2015","unstructured":"Husain-Krautter S, Kramer JM, Li W, Guo B, Rothstein TL (2015) The osteopontin transgenic mouse is a new model for Sj\u00f6gren\u2019s syndrome. Clin Immunol 157(1):30\u201342. https:\/\/doi.org\/10.1016\/j.clim.2014.12.010","journal-title":"Clin Immunol"},{"key":"932_CR38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clinbiochem.2018.07.003","volume":"59","author":"MA Icer","year":"2018","unstructured":"Icer MA, Gezmen-Karadag M (2018) The multiple functions and mechanisms of osteopontin. Clin Biochem 59:17\u201324","journal-title":"Clin Biochem"},{"issue":"12","key":"932_CR39","first-page":"1523","volume":"78","author":"J Iizuka","year":"1998","unstructured":"Iizuka J, Katagiri Y, Tada N, Murakami M, Ikeda T, Sato M et al (1998) Introduction of an osteopontin gene confers the increase in B1 cell population and the production of anti-DNA autoantibodies. Lab Invest 78(12):1523\u20131533","journal-title":"Lab Invest"},{"issue":"1","key":"932_CR40","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12026-010-8179-5","volume":"49","author":"M Inoue","year":"2011","unstructured":"Inoue M, Shinohara ML (2011) Intracellular osteopontin (iOPN) and immunity. Immunol Res 49(1):160\u2013172","journal-title":"Immunol Res"},{"issue":"1","key":"932_CR41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4049\/jimmunol.1002735","volume":"186","author":"M Inoue","year":"2011","unstructured":"Inoue M, Moriwaki Y, Arikawa T, Chen Y-H, Oh YJ, Oliver T, Shinohara ML (2011) Cutting edge: critical role of intracellular osteopontin in antifungal innate immune responses. J Immunol 186(1):19\u201323","journal-title":"J Immunol"},{"issue":"1","key":"932_CR42","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/1756-185X.12115","volume":"17","author":"H Iwadate","year":"2014","unstructured":"Iwadate H, Kobayashi H, Kanno T, Asano T, Saito R, Sato S et al (2014) Plasma osteopontin is correlated with bone resorption markers in rheumatoid arthritis patients. Int J Rheum Dis 17(1):50\u201356","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"932_CR43","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.4049\/jimmunol.168.5.2096","volume":"168","author":"M Jansson","year":"2002","unstructured":"Jansson M, Panoutsakopoulou V, Baker J, Klein L, Cantor H (2002) Cutting edge: attenuated experimental autoimmune encephalomyelitis in eta-1\/osteopontin-deficient mice. J Immunol 168(5):2096\u20132099","journal-title":"J Immunol"},{"issue":"3","key":"932_CR44","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10067-013-2375-3","volume":"33","author":"H-I Ji","year":"2014","unstructured":"Ji H-I, Lee S-H, Song R, Yang H-I, Lee Y-A, Hong S-J et al (2014) Serum level of osteopontin as an inflammatory marker does not indicate disease activity or responsiveness to therapeutic treatments in patients with rheumatoid arthritis. Clin Rheumatol 33(3):397\u2013402","journal-title":"Clin Rheumatol"},{"issue":"26","key":"932_CR45","doi-asserted-by":"crossref","first-page":"20197","DOI":"10.1074\/jbc.M909174199","volume":"275","author":"S Jono","year":"2000","unstructured":"Jono S, Peinado C, Giachelli CM (2000) Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J Biol Chem 275(26):20197\u201320203","journal-title":"J Biol Chem"},{"issue":"2","key":"932_CR46","doi-asserted-by":"crossref","first-page":"C919","DOI":"10.1152\/ajpcell.00477.2006","volume":"292","author":"A Junaid","year":"2007","unstructured":"Junaid A, Moon MC, Harding GE, Zahradka P (2007) Osteopontin localizes to the nucleus of 293 cells and associates with polo-like kinase-1. Am J Physiol Cell Physiol 292(2):C919\u2013C926","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6","key":"932_CR47","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00005-014-0294-x","volume":"62","author":"B Kaleta","year":"2014","unstructured":"Kaleta B (2014) Role of osteopontin in systemic lupus erythematosus. Arch Immunol Ther Exp 62(6):475\u2013482","journal-title":"Arch Immunol Ther Exp"},{"key":"932_CR48","doi-asserted-by":"crossref","first-page":"173209","DOI":"10.1016\/j.ejphar.2020.173209","volume":"881","author":"RN Kalmarzi","year":"2020","unstructured":"Kalmarzi RN, Rajabinejad M, Lotfi R (2020) Immune semaphorins: crucial regulatory signals and novel therapeutic targets in asthma and allergic diseases. Eur J Pharmacol 881:173209","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"932_CR49","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/ni.3791","volume":"18","author":"M Kanayama","year":"2017","unstructured":"Kanayama M, Xu S, Danzaki K, Gibson JR, Inoue M, Gregory SG, Shinohara ML (2017) Skewing of the population balance of lymphoid and myeloid cells by secreted and intracellular osteopontin. Nat Immunol 18(9):973\u2013984","journal-title":"Nat Immunol"},{"issue":"5","key":"932_CR50","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/gene.2009.15","volume":"10","author":"SN Kariuki","year":"2009","unstructured":"Kariuki SN, Moore JG, Kirou KA, Crow MK, Utset TO, Niewold TB (2009) Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus. Genes Immun 10(5):487\u2013494. https:\/\/doi.org\/10.1038\/gene.2009.15","journal-title":"Genes Immun"},{"issue":"1","key":"932_CR51","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1749-6632.1995.tb44660.x","volume":"760","author":"Y Katagiri","year":"1995","unstructured":"Katagiri Y, Mori K, Hara T, Tanaka K, Murakami M, Uede T (1995) Functional analysis of the osteopontin molecule. Ann N Y Acad Sci 760(1):371\u2013374","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"932_CR52","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1128\/CDLI.12.1.206-212.2005","volume":"12","author":"K Kawamura","year":"2005","unstructured":"Kawamura K, Iyonaga K, Ichiyasu H, Nagano J, Suga M, Sasaki Y (2005) Differentiation, maturation, and survival of dendritic cells by osteopontin regulation. Clin Vaccine Immunol 12(1):206\u2013212","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"932_CR53","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1186\/s12891-021-04392-5","volume":"22","author":"S-Y Kawashiri","year":"2021","unstructured":"Kawashiri S-Y, Endo Y, Nishino A, Okamoto M, Tsuji S, Takatani A et al (2021) Association between serum bone biomarker levels and therapeutic response to abatacept in patients with rheumatoid arthritis (RA): a multicenter, prospective, and observational RA ultrasound cohort study in Japan. BMC Musculoskelet Disord 22(1):506. https:\/\/doi.org\/10.1186\/s12891-021-04392-5","journal-title":"BMC Musculoskelet Disord"},{"issue":"4","key":"932_CR54","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/jcb.21558","volume":"102","author":"CC Kazanecki","year":"2007","unstructured":"Kazanecki CC, Uzwiak DJ, Denhardt DT (2007) Control of osteopontin signaling and function by post-translational phosphorylation and protein folding. J Cell Biochem 102(4):912\u2013924","journal-title":"J Cell Biochem"},{"issue":"4","key":"932_CR55","doi-asserted-by":"publisher","first-page":"935","DOI":"10.2337\/db09-0404","volume":"59","author":"FW Kiefer","year":"2010","unstructured":"Kiefer FW, Zeyda M, Gollinger K, Pfau B, Neuhofer A, Weichhart T et al (2010) Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance. Diabetes 59(4):935\u2013946. https:\/\/doi.org\/10.2337\/db09-0404","journal-title":"Diabetes"},{"issue":"7","key":"932_CR56","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.4103\/1673-5374.330614","volume":"17","author":"J Kim","year":"2022","unstructured":"Kim J, Ahn M, Choi Y, Chun J, Jung K, Tanaka A et al (2022) Osteopontin is a biomarker for early autoimmune uveoretinitis. Neural Regen Res 17(7):1604","journal-title":"Neural Regen Res"},{"issue":"2","key":"932_CR57","doi-asserted-by":"publisher","first-page":"118","DOI":"10.2177\/jsci.40.118","volume":"40","author":"K Kitagori","year":"2017","unstructured":"Kitagori K, Yoshifuji H (2017) Osteopontin in systemic lupus erythematosus. Nihon Rinsho Meneki Gakkai Kaishi 40(2):118\u2013123. https:\/\/doi.org\/10.2177\/jsci.40.118","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"issue":"12","key":"932_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167141","volume":"11","author":"K Kitagori","year":"2016","unstructured":"Kitagori K, Yoshifuji H, Oku T, Sasaki C, Miyata H, Mori KP et al (2016) Cleaved form of osteopontin in urine as a clinical marker of lupus nephritis. PLoS ONE 11(12):e0167141. https:\/\/doi.org\/10.1371\/journal.pone.0167141","journal-title":"PLoS ONE"},{"issue":"4","key":"932_CR59","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1177\/1352458513503052","volume":"20","author":"P Kivis\u00e4kk","year":"2013","unstructured":"Kivis\u00e4kk P, Healy BC, Francois K, Gandhi R, Gholipour T, Egorova S et al (2013) Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development. Mult Scler J 20(4):438\u2013444. https:\/\/doi.org\/10.1177\/1352458513503052","journal-title":"Mult Scler J"},{"issue":"4","key":"932_CR60","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1177\/1352458513503052","volume":"20","author":"P Kivis\u00e4kk","year":"2014","unstructured":"Kivis\u00e4kk P, Healy BC, Francois K, Gandhi R, Gholipour T, Egorova S et al (2014) Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development. Mult Scler 20(4):438\u2013444. https:\/\/doi.org\/10.1177\/1352458513503052","journal-title":"Mult Scler"},{"issue":"1","key":"932_CR61","doi-asserted-by":"publisher","first-page":"38","DOI":"10.9738\/intsurg-d-13-00160.1","volume":"100","author":"S Komine-Aizawa","year":"2015","unstructured":"Komine-Aizawa S, Masuda H, Mazaki T, Shiono M, Hayakawa S, Takayama T (2015) Plasma osteopontin predicts inflammatory bowel disease activities. Int Surg 100(1):38\u201343. https:\/\/doi.org\/10.9738\/intsurg-d-13-00160.1","journal-title":"Int Surg"},{"issue":"12","key":"932_CR62","volume":"9","author":"S Kon","year":"2014","unstructured":"Kon S, Nakayama Y, Matsumoto N, Ito K, Kanayama M, Kimura C et al (2014) A novel cryptic binding motif, LRSKSRSFQVSDEQY, in the C-terminal fragment of MMP-3\/7-cleaved osteopontin as a novel ligand for \u03b19\u03b21 integrin is involved in the anti-type II collagen antibody-induced arthritis. PLoS ONE 9(12):e116210","journal-title":"PLoS ONE"},{"issue":"9","key":"932_CR63","doi-asserted-by":"publisher","first-page":"E856","DOI":"10.1073\/pnas.1316447111","volume":"111","author":"E Kourepini","year":"2014","unstructured":"Kourepini E, Aggelakopoulou M, Alissafi T, Paschalidis N, Simoes DC, Panoutsakopoulou V (2014) Osteopontin expression by CD103- dendritic cells drives intestinal inflammation. Proc Natl Acad Sci USA 111(9):E856-865. https:\/\/doi.org\/10.1073\/pnas.1316447111","journal-title":"Proc Natl Acad Sci USA"},{"issue":"31","key":"932_CR64","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1021\/bi400502c","volume":"52","author":"D Kurzbach","year":"2013","unstructured":"Kurzbach D, Platzer G, Schwarz TC, Henen MA, Konrat R, Hinderberger D (2013) Cooperative unfolding of compact conformations of the intrinsically disordered protein osteopontin. Biochemistry 52(31):5167\u20135175","journal-title":"Biochemistry"},{"issue":"9","key":"932_CR65","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.4049\/jimmunol.147.9.2902","volume":"147","author":"MA Lampe","year":"1991","unstructured":"Lampe MA, Patarca R, Iregui MV, Cantor H (1991) Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease. J Immunol 147(9):2902\u20132906","journal-title":"J Immunol"},{"issue":"2","key":"932_CR66","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1073\/pnas.1423011112","volume":"112","author":"JW Leavenworth","year":"2015","unstructured":"Leavenworth JW, Verbinnen B, Wang Q, Shen E, Cantor H (2015a) Intracellular osteopontin regulates homeostasis and function of natural killer cells. Proc Natl Acad Sci 112(2):494\u2013499","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"932_CR67","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/ni.3050","volume":"16","author":"JW Leavenworth","year":"2015","unstructured":"Leavenworth JW, Verbinnen B, Yin J, Huang H, Cantor H (2015b) A p85\u03b1-osteopontin axis couples the receptor ICOS to sustained Bcl-6 expression by follicular helper and regulatory T cells. Nat Immunol 16(1):96\u2013106. https:\/\/doi.org\/10.1038\/ni.3050","journal-title":"Nat Immunol"},{"issue":"3","key":"932_CR68","first-page":"2681","volume":"15","author":"Y Liu","year":"2018","unstructured":"Liu Y, Qian K, Li C, Ma Y, Chen X (2018) Roles of microRNA-539 and osteopontin in rheumatoid arthritis. Exp Ther Med 15(3):2681\u20132687","journal-title":"Exp Ther Med"},{"key":"932_CR69","doi-asserted-by":"publisher","unstructured":"Maghraby HM, Refaei KE, Hassan MA, Hassan AS, AbdElazeem A (2018) Role of osteopontin in systemic lupus erythematosus. Int Ann Med. https:\/\/doi.org\/10.24087\/IAM.2018.2.2.417","DOI":"10.24087\/IAM.2018.2.2.417"},{"issue":"28","key":"932_CR70","doi-asserted-by":"crossref","first-page":"20959","DOI":"10.1074\/jbc.C000290200","volume":"275","author":"UM Malyankar","year":"2000","unstructured":"Malyankar UM, Scatena M, Suchland KL, Yun TJ, Clark EA, Giachelli CM (2000) Osteoprotegerin is an \u03b1v\u03b23-induced, NF-\u03baB-dependent survival factor for endothelial cells. J Biol Chem 275(28):20959\u201320962","journal-title":"J Biol Chem"},{"issue":"6","key":"932_CR71","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000001083","volume":"8","author":"D Marastoni","year":"2021","unstructured":"Marastoni D, Magliozzi R, Bolzan A, Pisani AI, Rossi S, Crescenzo F et al (2021) CSF levels of CXCL12 and osteopontin as early markers of primary progressive multiple sclerosis. Neurol - Neuroimmunol Neuroinflamm 8(6):e1083. https:\/\/doi.org\/10.1212\/nxi.0000000000001083","journal-title":"Neurol - Neuroimmunol Neuroinflamm"},{"issue":"5","key":"932_CR72","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/bjp.2008.317","volume":"155","author":"P McClean","year":"2008","unstructured":"McClean P, Irwin N, Hunter K, Gault V, Flatt P (2008) (Pro3) GIP [mPEG]: novel, long-acting, mPEGylated antagonist of gastric inhibitory polypeptide for obesity-diabetes (diabesity) therapy. Br J Pharmacol 155(5):690\u2013701","journal-title":"Br J Pharmacol"},{"issue":"23","key":"932_CR73","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365(23):2205\u20132219","journal-title":"N Engl J Med"},{"key":"932_CR74","doi-asserted-by":"crossref","first-page":"144785","DOI":"10.1016\/j.gene.2020.144785","volume":"753","author":"E Melanitou","year":"2020","unstructured":"Melanitou E (2020) Investigation of type 1 diabetes in NOD mice knockout for the osteopontin gene. Gene 753:144785","journal-title":"Gene"},{"issue":"5","key":"932_CR75","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1002\/eji.200425672","volume":"35","author":"T Miyazaki","year":"2005","unstructured":"Miyazaki T, Ono M, Qu WM, Zhang MC, Mori S, Nakatsuru S et al (2005) Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL\/lpr mice. Eur J Immunol 35(5):1510\u20131520. https:\/\/doi.org\/10.1002\/eji.200425672","journal-title":"Eur J Immunol"},{"issue":"4","key":"932_CR76","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2174\/138945010790980321","volume":"11","author":"J Morimoto","year":"2010","unstructured":"Morimoto J, Kon S, Matsui Y, Uede T (2010) Osteopontin, as a target molecule for the treatment of inflammatory diseases. Curr Drug Targets 11(4):494\u2013505","journal-title":"Curr Drug Targets"},{"issue":"11","key":"932_CR77","doi-asserted-by":"crossref","first-page":"7480","DOI":"10.4049\/jimmunol.181.11.7480","volume":"181","author":"G Murugaiyan","year":"2008","unstructured":"Murugaiyan G, Mittal A, Weiner HL (2008) Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis. J Immunol 181(11):7480\u20137488","journal-title":"J Immunol"},{"issue":"10","key":"932_CR78","first-page":"2061","volume":"29","author":"S Ohshima","year":"2002","unstructured":"Ohshima S, Yamaguchi N, Nishioka K, Mima T, Ishii T, Umeshita-Sasai M et al (2002) Enhanced local production of osteopontin in rheumatoid joints. J Rheumatol 29(10):2061\u20132067","journal-title":"J Rheumatol"},{"key":"932_CR79","doi-asserted-by":"publisher","DOI":"10.7326\/AITC202106150","author":"MJ Olek","year":"2021","unstructured":"Olek MJ (2021) Multiple sclerosis. Ann Intern Med. https:\/\/doi.org\/10.7326\/AITC202106150","journal-title":"Ann Intern Med"},{"issue":"2","key":"932_CR80","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1046\/j.1523-1755.1999.00580.x","volume":"56","author":"V Ophascharoensuk","year":"1999","unstructured":"Ophascharoensuk V, Giachelli CM, Gordon K, Hughes J, Pichler R, Brown P et al (1999) Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int 56(2):571\u2013580. https:\/\/doi.org\/10.1046\/j.1523-1755.1999.00580.x","journal-title":"Kidney Int"},{"issue":"24","key":"932_CR81","doi-asserted-by":"crossref","first-page":"14175","DOI":"10.1073\/pnas.2336198100","volume":"100","author":"M Pellegrini","year":"2003","unstructured":"Pellegrini M, Belz G, Bouillet P, Strasser A (2003) Shutdown of an acute T cell immune response to viral infection is mediated by the proapoptotic Bcl-2 homology 3-only protein Bim. Proc Natl Acad Sci 100(24):14175\u201314180","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"932_CR82","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0022-510X(91)90219-W","volume":"104","author":"M Pender","year":"1991","unstructured":"Pender M, Nguyen K, McCombe P, Kerr J (1991) Apoptosis in the nervous system in experimental allergic encephalomyelitis. J Neurol Sci 104(1):81\u201387","journal-title":"J Neurol Sci"},{"issue":"7","key":"932_CR83","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/1529-0131(200007)43:7<1597::AID-ANR25>3.0.CO;2-0","volume":"43","author":"PK Petrow","year":"2000","unstructured":"Petrow PK, Hummel KM, Schedel J, Franz JK, Klein CL, M\u00fcller-Ladner U et al (2000) Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: effects of osteopontin on the release of collagenase 1 from articular chondrocytes and synovial fibroblasts. Arthritis Rheum 43(7):1597\u20131605","journal-title":"Arthritis Rheum"},{"issue":"10","key":"932_CR84","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41584-020-0480-7","volume":"16","author":"DS Pisetsky","year":"2020","unstructured":"Pisetsky DS, Lipsky PE (2020) New insights into the role of antinuclear antibodies in systemic lupus erythematosus. Nat Rev Rheumatol 16(10):565\u2013579","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"932_CR85","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1002\/iub.2387","volume":"72","author":"F Radmanesh","year":"2020","unstructured":"Radmanesh F, Mahmoudi M, Yazdanpanah E, Keyvani V, Kia N, Nikpoor AR et al (2020) The immunomodulatory effects of mesenchymal stromal cell-based therapy in human and animal models of systemic lupus erythematosus. IUBMB Life 72(11):2366\u20132381","journal-title":"IUBMB Life"},{"issue":"6","key":"932_CR86","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1002\/jcp.29401","volume":"235","author":"M Rajabinejad","year":"2020","unstructured":"Rajabinejad M, Ranjbar S, Afshar Hezarkhani L, Salari F, Gorgin Karaji A, Rezaiemanesh A (2020) Regulatory T cells for amyotrophic lateral sclerosis\/motor neuron disease: a clinical and preclinical systematic review. J Cell Physiol 235(6):5030\u20135040","journal-title":"J Cell Physiol"},{"issue":"3","key":"932_CR87","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2004-08-3228","volume":"106","author":"AC Renkl","year":"2005","unstructured":"Renkl AC, Wussler J, Ahrens T, Thoma K, Kon S, Uede T et al (2005) Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype. Blood 106(3):946\u2013955","journal-title":"Blood"},{"issue":"12","key":"932_CR88","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1177\/0022034515605270","volume":"94","author":"S Rittling","year":"2015","unstructured":"Rittling S, Singh R (2015) Osteopontin in immune-mediated diseases. J Dent Res 94(12):1638\u20131645","journal-title":"J Dent Res"},{"issue":"1","key":"932_CR89","doi-asserted-by":"publisher","first-page":"R18","DOI":"10.1186\/ar4150","volume":"15","author":"OJ Rullo","year":"2013","unstructured":"Rullo OJ, Woo JM, Parsa MF, Hoftman AD, Maranian P, Elashoff DA et al (2013) Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus. Arthritis Res Ther 15(1):R18. https:\/\/doi.org\/10.1186\/ar4150","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"932_CR90","first-page":"1492","volume":"28","author":"M Sakata","year":"2001","unstructured":"Sakata M, Tsuruha J-I, Masuko-Hongo K, Nakamura H, Matsui T, Sudo A et al (2001) Autoantibodies to osteopontin in patients with osteoarthritis and rheumatoid arthritis. J Rheumatol 28(7):1492\u20131495","journal-title":"J Rheumatol"},{"issue":"6","key":"932_CR91","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1007\/s11033-019-05078-x","volume":"46","author":"Z Samimi","year":"2019","unstructured":"Samimi Z, Kardideh B, Zafari P, Bahrehmand F, Roghani SA, Taghadosi M (2019) The impaired gene expression of adenosine monophosphate-activated kinase (AMPK), a key metabolic enzyme in leukocytes of newly diagnosed rheumatoid arthritis patients. Mol Biol Rep 46(6):6353\u20136360","journal-title":"Mol Biol Rep"},{"issue":"10","key":"932_CR92","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1038\/jid.2008.112","volume":"128","author":"G Schulz","year":"2008","unstructured":"Schulz G, Renkl AC, Seier A, Liaw L, Weiss JM (2008) Regulated osteopontin expression by dendritic cells decisively affects their migratory capacity. J Invest Dermatol 128(10):2541","journal-title":"J Invest Dermatol"},{"issue":"4","key":"932_CR93","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/0092-8674(79)90103-X","volume":"16","author":"DR Senger","year":"1979","unstructured":"Senger DR, Wirth DF, Hynes RO (1979) Transformed mammalian cells secrete specific proteins and phosphoproteins. Cell 16(4):885\u2013893","journal-title":"Cell"},{"issue":"4","key":"932_CR94","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.bbrc.2017.10.009","volume":"493","author":"L Shao","year":"2017","unstructured":"Shao L, Zhang B, Wang L, Wu L, Kan Q, Fan K (2017) MMP-9-cleaved osteopontin isoform mediates tumor immune escape by inducing expansion of myeloid-derived suppressor cells. Biochem Biophys Res Commun 493(4):1478\u20131484","journal-title":"Biochem Biophys Res Commun"},{"issue":"1\u20132","key":"932_CR95","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jneuroim.2013.07.005","volume":"263","author":"Y Shimizu","year":"2013","unstructured":"Shimizu Y, Ota K, Ikeguchi R, Kubo S, Kabasawa C, Uchiyama S (2013) Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica. J Neuroimmunol 263(1\u20132):148\u2013151. https:\/\/doi.org\/10.1016\/j.jneuroim.2013.07.005","journal-title":"J Neuroimmunol"},{"issue":"5","key":"932_CR96","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/ni1327","volume":"7","author":"ML Shinohara","year":"2006","unstructured":"Shinohara ML, Lu L, Bu J, Werneck MB, Kobayashi KS, Glimcher LH, Cantor H (2006) Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. Nat Immunol 7(5):498\u2013506. https:\/\/doi.org\/10.1038\/ni1327","journal-title":"Nat Immunol"},{"issue":"1","key":"932_CR97","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2741\/2059","volume":"12","author":"M Singh","year":"2007","unstructured":"Singh M, Ananthula S, Milhorn DM, Krishnaswamy G, Singh K (2007) Osteopontin: a novel inflammatory mediator of cardiovascular disease. Front Biosci 12(1):214\u2013221","journal-title":"Front Biosci"},{"issue":"3","key":"932_CR98","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/10454411000110030101","volume":"11","author":"J Sodek","year":"2000","unstructured":"Sodek J, Ganss B, McKee M (2000) Osteopontin. Crit Rev Oral Biol Med 11(3):279\u2013303","journal-title":"Crit Rev Oral Biol Med"},{"issue":"6","key":"932_CR99","first-page":"899","volume":"37","author":"FR Spinelli","year":"2019","unstructured":"Spinelli FR, Garufi C, Truglia S, Pacucci VA, Morello F, Miranda F et al (2019) The role of osteopontin as a candidate biomarker of renal involvement in systemic lupus erythematosus. Clin Exp Rheumatol 37(6):899\u2013905","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"932_CR100","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nri2548","volume":"9","author":"L Steinman","year":"2009","unstructured":"Steinman L (2009) A molecular trio in relapse and remission in multiple sclerosis. Nat Rev Immunol 9(6):440\u2013447","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"932_CR101","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/gt.2009.66","volume":"16","author":"M Takanashi","year":"2009","unstructured":"Takanashi M, Oikawa K, Sudo K, Tanaka M, Fujita K, Ishikawa A et al (2009) Therapeutic silencing of an endogenous gene by siRNA cream in an arthritis model mouse. Gene Ther 16(8):982\u2013989","journal-title":"Gene Ther"},{"issue":"12","key":"932_CR102","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1002\/art.25020","volume":"60","author":"Y Take","year":"2009","unstructured":"Take Y, Nakata K, Hashimoto J, Tsuboi H, Nishimoto N, Ochi T, Yoshikawa H (2009) Specifically modified osteopontin in rheumatoid arthritis fibroblast-like synoviocytes supports interaction with B cells and enhances production of interleukin-6. Arthritis Rheum 60(12):3591\u20133601","journal-title":"Arthritis Rheum"},{"issue":"11","key":"932_CR103","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1097\/mib.0000000000000192","volume":"20","author":"R Tang","year":"2014","unstructured":"Tang R, Yang G, Zhang S, Wu C, Chen M (2014) Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-\u03b1 in inflammatory bowel disease. Inflamm Bowel Dis 20(11):1950\u20131961. https:\/\/doi.org\/10.1097\/mib.0000000000000192","journal-title":"Inflamm Bowel Dis"},{"key":"932_CR104","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/802581","volume":"2011","author":"T Trivedi","year":"2011","unstructured":"Trivedi T, Franek BS, Green SL, Kariuki SN, Kumabe M, Mikolaitis RA et al (2011) Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus. J Biomed Biotechnol 2011:802581. https:\/\/doi.org\/10.1155\/2011\/802581","journal-title":"J Biomed Biotechnol"},{"issue":"6","key":"932_CR105","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41590-020-0677-6","volume":"21","author":"GC Tsokos","year":"2020","unstructured":"Tsokos GC (2020) Autoimmunity and organ damage in systemic lupus erythematosus. Nat Immunol 21(6):605\u2013614","journal-title":"Nat Immunol"},{"issue":"5","key":"932_CR106","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1440-1827.2011.02649.x","volume":"61","author":"T Uede","year":"2011","unstructured":"Uede T (2011) Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases. Pathol Int 61(5):265\u2013280","journal-title":"Pathol Int"},{"issue":"1\u20132","key":"932_CR107","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jneuroim.2004.06.007","volume":"155","author":"M Vogt","year":"2004","unstructured":"Vogt M, Floris S, Killestein J, Knol D, Smits M, Barkhof F et al (2004) Osteopontin levels and increased disease activity in relapsing\u2013remitting multiple sclerosis patients. J Neuroimmunol 155(1\u20132):155\u2013160","journal-title":"J Neuroimmunol"},{"issue":"5\u20136","key":"932_CR108","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cytogfr.2008.08.001","volume":"19","author":"KX Wang","year":"2008","unstructured":"Wang KX, Denhardt DT (2008) Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev 19(5\u20136):333\u2013345","journal-title":"Cytokine Growth Factor Rev"},{"issue":"9","key":"932_CR109","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.3390\/ijms19092557","volume":"19","author":"GF Weber","year":"2018","unstructured":"Weber GF (2018) The Phylogeny of osteopontin\u2014analysis of the protein sequence. Int J Mol Sci 19(9):2557","journal-title":"Int J Mol Sci"},{"issue":"3","key":"932_CR110","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1046\/j.1365-2249.2001.01702.x","volume":"126","author":"GF Weber","year":"2001","unstructured":"Weber GF, Cantor H (2001) Differential roles of osteopontin\/Eta-1 in early and late lpr disease. Clin Exp Immunol 126(3):578\u2013583. https:\/\/doi.org\/10.1046\/j.1365-2249.2001.01702.x","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"932_CR111","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1084\/jem.194.9.1219","volume":"194","author":"J Weiss","year":"2001","unstructured":"Weiss J, Renkl A, Maier C, Kimmig M, Liaw L, Ahrens T et al (2001) Osteopontin is involved in the initiation of cutaneous contact hypersensitivity by inducing Langerhans and dendritic cell migration to lymph nodes. J Exp Med 194(9):1219\u20131230","journal-title":"J Exp Med"},{"issue":"5","key":"932_CR112","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1093\/rheumatology\/keh558","volume":"44","author":"CK Wong","year":"2005","unstructured":"Wong CK, Lit LC, Tam LS, Li EK, Lam CW (2005) Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus. Rheumatology (oxford) 44(5):602\u2013606. https:\/\/doi.org\/10.1093\/rheumatology\/keh558","journal-title":"Rheumatology (oxford)"},{"issue":"3","key":"932_CR113","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3109\/08916939808996282","volume":"28","author":"RP W\u00fcthrich","year":"1998","unstructured":"W\u00fcthrich RP, Fan X, Ritthaler T, Sibalic V, Yu DJ, Loffing J, Kaissling B (1998) Enhanced osteopontin expression and macrophage infiltration in MRL-Fas(lpr) mice with lupus nephritis. Autoimmunity 28(3):139\u2013150. https:\/\/doi.org\/10.3109\/08916939808996282","journal-title":"Autoimmunity"},{"issue":"4","key":"932_CR114","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1172\/JCI200523273","volume":"115","author":"G Xu","year":"2005","unstructured":"Xu G, Nie H, Li N, Zheng W, Zhang D, Feng G et al (2005) Role of osteopontin in amplification and perpetuation of rheumatoid synovitis. J Clin Investig 115(4):1060\u20131067","journal-title":"J Clin Investig"},{"issue":"3","key":"932_CR115","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.bbrc.2010.02.030","volume":"393","author":"Y Yamaguchi","year":"2010","unstructured":"Yamaguchi Y, Hanashima S, Yagi H, Takahashi Y, Sasakawa H, Kurimoto E et al (2010) NMR characterization of intramolecular interaction of osteopontin, an intrinsically disordered protein with cryptic integrin-binding motifs. Biochem Biophys Res Commun 393(3):487\u2013491","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"932_CR116","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.intimp.2007.06.009","volume":"7","author":"N Yamamoto","year":"2007","unstructured":"Yamamoto N, Nakashima T, Torikai M, Naruse T, Morimoto J, Kon S et al (2007) Successful treatment of collagen-induced arthritis in non-human primates by chimeric anti-osteopontin antibody. Int Immunopharmacol 7(11):1460\u20131470","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"932_CR117","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1073\/pnas.052523599","volume":"99","author":"K Yumoto","year":"2002","unstructured":"Yumoto K, Ishijima M, Rittling SR, Tsuji K, Tsuchiya Y, Kon S et al (2002) Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice. Proc Natl Acad Sci 99(7):4556\u20134561","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"932_CR118","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00296-014-3122-z","volume":"35","author":"F Zhang","year":"2015","unstructured":"Zhang F, Luo W, Li Y, Gao S, Lei G (2015a) Role of osteopontin in rheumatoid arthritis. Rheumatol Int 35(4):589\u2013595","journal-title":"Rheumatol Int"},{"issue":"8","key":"932_CR119","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/aps.2015.37","volume":"36","author":"Y-M Zhang","year":"2015","unstructured":"Zhang Y-M, Li M-X, Tang Z, Wang C-H (2015b) Wogonin suppresses osteopontin expression in adipocytes by activating PPAR\u03b1. Acta Pharmacol Sin 36(8):987\u2013997. https:\/\/doi.org\/10.1038\/aps.2015.37","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"932_CR120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"K Zhao","year":"2016","unstructured":"Zhao K, Zhang M, Zhang L, Wang P, Song G, Liu B et al (2016) Intracellular osteopontin stabilizes TRAF3 to positively regulate innate antiviral response. Sci Rep 6(1):1\u201313","journal-title":"Sci Rep"},{"key":"932_CR121","doi-asserted-by":"crossref","first-page":"106335","DOI":"10.1016\/j.intimp.2020.106335","volume":"82","author":"J Zhao","year":"2020","unstructured":"Zhao J, Jing J, Zhao W, Li X, Hou L, Zheng C et al (2020) Osteopontin exacerbates the progression of experimental autoimmune myasthenia gravis by affecting the differentiation of T cell subsets. Int Immunopharmacol 82:106335","journal-title":"Int Immunopharmacol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-00932-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-022-00932-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-00932-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T06:33:54Z","timestamp":1674887634000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-022-00932-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,2]]},"references-count":121,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["932"],"URL":"https:\/\/doi.org\/10.1007\/s10787-022-00932-0","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,2]]},"assertion":[{"value":"14 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"It is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"It is not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}